dc.creator | Reyes-Parada M. | |
dc.creator | Iturriaga-Vasquez P. | |
dc.creator | Cassels B.K. | |
dc.date.accessioned | 2020-09-02T22:26:59Z | |
dc.date.accessioned | 2022-11-08T20:21:05Z | |
dc.date.available | 2020-09-02T22:26:59Z | |
dc.date.available | 2022-11-08T20:21:05Z | |
dc.date.created | 2020-09-02T22:26:59Z | |
dc.date.issued | 2020 | |
dc.identifier | 10, , - | |
dc.identifier | 16639812 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6012 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143873 | |
dc.language | en | |
dc.publisher | Frontiers Media S.A. | |
dc.subject | Amphetamine derivatives | |
dc.subject | Dopamine transporter | |
dc.subject | Monoamine oxidase | |
dc.subject | Monoamine oxidase-A | |
dc.subject | Norepinephrine transporter | |
dc.subject | Serotonin syndrome | |
dc.subject | Serotonin transporter | |
dc.subject | 2,6 dichloro 4 dimethylaminoamphetamine | |
dc.subject | 4 iodo 2,5 dimethoxyamphetamine | |
dc.subject | aliphatic compound | |
dc.subject | amiflamine | |
dc.subject | amine oxidase (flavin containing) | |
dc.subject | amino acid derivative | |
dc.subject | amphetamine derivative | |
dc.subject | aromatic compound | |
dc.subject | cathinone | |
dc.subject | fenfluramine | |
dc.subject | fla 289 | |
dc.subject | fla 314 | |
dc.subject | fla 384 | |
dc.subject | fla 405 | |
dc.subject | fla 450 | |
dc.subject | fla 463 | |
dc.subject | fla 558 | |
dc.subject | fla 717 | |
dc.subject | fla 727 | |
dc.subject | fla 788 | |
dc.subject | methamphetamine | |
dc.subject | monoamine oxidase A inhibitor | |
dc.subject | monoamine oxidase B inhibitor | |
dc.subject | monoamine oxidase inhibitor | |
dc.subject | phenethylamine | |
dc.subject | phentermine | |
dc.subject | serotonin receptor | |
dc.subject | unclassified drug | |
dc.subject | antidepressant activity | |
dc.subject | Article | |
dc.subject | binding affinity | |
dc.subject | chemical modification | |
dc.subject | drug binding site | |
dc.subject | drug identification | |
dc.subject | drug potency | |
dc.subject | drug receptor binding | |
dc.subject | drug targeting | |
dc.subject | enantioselectivity | |
dc.subject | enzyme inhibition | |
dc.subject | human | |
dc.subject | molecular docking | |
dc.subject | nonhuman | |
dc.subject | structure activity relation | |
dc.subject | structure analysis | |
dc.subject | tranquilizing activity | |
dc.title | Amphetamine derivatives as monoamine oxidase inhibitors | |
dc.type | Article | |